Information for Glucagon
Page information·measured at build time
Technical and provenance information about Glucagon. All figures on this page are measured from the emitted page rather than declared.
Basic information
| Display title | Glucagon |
|---|---|
| Default sort key | Glucagon |
| Namespace | Article (main) |
| Page kind | Compound |
| Page length (source, bytes) | 7,074 |
| Rendered word count | 844 |
| Internal wiki links on the page | 21 |
| Defined citations | 4 |
| Top-level sections | 4 |
| Subsections | 0 |
| Tables | 0 |
| Figures | 0 |
| Infobox | Yes — compound |
| Maintenance banners | None |
| Indexing by robots | Allowed |
Edit history
| Page creator | ShortDescShai |
|---|---|
| Date of page creation | 15 July 2024 |
| Latest editor | TSH_Tallulah |
| Date of latest edit | 19 July 2026 |
| Total number of edits | 31 |
| Total number of distinct authors | 29 |
| Minor edits | 14 |
| Automated (bot) edits | 2 |
| Recent number of edits (last 90 days) | 3 |
| Talk page posts | 7 |
Principal authors
| Editor | Edits | Share | Declared focus |
|---|---|---|---|
| CuriousCallum | 2 | 6.5% | GLP-1 receptor agonists and related compounds |
| TirzTaxonomist | 2 | 6.5% | GLP-1 receptor agonists and related compounds |
| ShortDescShai | 1 | 3.2% | copy-editing and the manual of style |
| MissedDoseMik | 1 | 3.2% | dosing, titration and injection practice |
| ComparisonCato | 1 | 3.2% | GLP-1 receptor agonists and related compounds |
| RetatrutideRuben | 1 | 3.2% | GLP-1 receptor agonists and related compounds |
| MazdutideMads | 1 | 3.2% | GLP-1 receptor agonists and related compounds |
| SemaglutideSasha | 1 | 3.2% | GLP-1 receptor agonists and related compounds |
| SurvodutideSaff | 1 | 3.2% | GLP-1 receptor agonists and related compounds |
| DulaglutideDug | 1 | 3.2% | GLP-1 receptor agonists and related compounds |
| VerifyVesna | 1 | 3.2% | third-party testing and certificates of analysis |
| OrforglipronOona | 1 | 3.2% | GLP-1 receptor agonists and related compounds |
Category membership
- Category:Peptide drugs — 17 member pages
- Category:Incretin biology — 14 member pages
- Category:Compounds and pharmacology — 11 member pages